Prof Anant Madabhushi speaks to ecancer about AI in multiple myeloma: Recent findings and opportunities.

AI is evolving in the field of myeloma, presenting significant opportunities for application.

While myeloma research is limited, it opens doors for AI in digital pathology and risk assessment.

AI can predict myeloma development and enhance therapy response predictions, contributing to precision medicine.

Discussions also address resource disparities and the need for equitable AI tools, especially in low-income countries, highlighting the global potential of AI technologies.